Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This clinical trial is conducted in Europe. The purpose of the trial is to investigate the
influence on the pharmacokinetics (the rate at which the trial drug is eliminated from the
body) of an oral contraceptive combination drug after multiple administration of semaglutide
in female subjects with type 2 diabetes.